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A B S T R A C T
Worldwide, biologically active pharmaceuticals, such as psychoactive drugs, are routinely detected in aquatic
ecosystems. In this regard, selective serotonin reuptake inhibitors (SSRIs), a class of antidepressant, are of major
environmental concern. Through targeted action on evolutionarily conserved physiological pathways, SSRIs could
alter ecologically important behaviours in exposed organisms. Here, using two field-realistic dosages (measured
concentrations: 18 and 215 ng/L) of the SSRI fluoxetine (Prozac), we examined the effects of exposure on anxiety-
related behaviours in wild-caught female mosquitofish, Gambusia holbrooki. Anxiety-related behaviour was assessed
using a light/dark transition test, with the swimming activity of fish recorded under two alternating light conditions,
complete darkness and bright light, with the shift in light condition used to induce an anxiety-like response.
Fluoxetine exposure resulted in a nonmonotonic decrease in anxiety-related behaviour (i.e. nonlinear with dose),
with fish in the low-fluoxetine treatment being less responsive to shifts in light condition compared to unexposed
fish. There was no such difference between unexposed and high-exposed fish. Further, we detected a significant
interaction between exposure treatment and fish weight on general swimming activity, suggesting the presence of a
mass-specific effect of fluoxetine. More broadly, contaminant-induced disruption of animal behaviour—as
documented here—could have wide-reaching effects on population-level fitness.









Pharmaceutical pollution is a rapidly emerging global issue, with
large quantities of biologically active drugs making their way into the
environment [1,2]. In this regard, psychoactive pharmaceuticals—
including selective serotonin reuptake inhibitors (SSRIs)—are frequently
detected in aquatic ecosystems [3–5]. Due to non-existent [6] or
inadequate [7,8] wastewater treatment, these SSRI antidepressants can
enter aquatic systems, and have been repeatably detected in the tissues of
wildlife [9–11]. A recent review on global surface water concentrations of
SSRIs reported a range of <0.1–351 ng/L in freshwater environments [5],
but higher concentrations have been reported in effluent-dominated
systems (e.g. [12]).
Selective serotonin reuptake inhibitors bind to, and block, the
serotonin transporter molecule [13]. Since the serotonin transporter
molecule, and the serotonergic system more generally, are evolutionary
conserved across taxa [14], these drugs have the potential to affect non-
target wildlife [15]. For example, SSRIs can alter anxiety-related
behaviour via the hypothalamic–pituitary–interrenal (HPI) axis by
influencing the production of corticotropin-releasing hormone and
adrenocorticotropic hormone, as well as cortisol secretion [15]. For this
reason, disruption of anxiety-related behaviours is a sensible endpoint to
test the risk posed by SSRI exposure. Further, from an ecological
perspective, shifts in anxiety-related behaviour can have crucial direct
and indirect consequences for health and survival [16], because anxiety is
known to regulate ecologically important processes like predatorprey
interactions [17].
Currently, however, there appears to be substantial incongruity in the
reported effects of SSRIs on anxiety-related behaviours of non-target
species, and the primary cause for these differences remain unclear [18].
This is particularly true for fluoxetine [18–21]—the most widespread
SSRI pollutant [5]. This variability in reported effects makes assessing the
environmental hazards posed by SSRIs difficult. If we are to understand
the risks posed by this group of contaminants, and the potential
mechanisms driving this heterogeneity, there is a clear need for further
research.
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Accordingly, the aim of this study was to test whether fluoxetine, at
two environmentally realistic concentrations, affects anxiety-related
behaviours of wild-caught female mosquitofish (Gambusia holbrooki)
using a light/dark transition test. More specifically, we predicted that
fluoxetine exposure will reduce the responsiveness of mosquitofish to
shifts in environmental light condition (i.e. complete dark to bright
light)—an anxiety-inducing stimulus. Further, based on emerging
evidence (e.g. [19,22,23]), we predicted that the reduction in anxiety-
like behaviour will be nonmonotonic, with stronger effects seen at the
lower dosage employed.
Materials and methods
Fish collection, housing, and exposure
Adult female mosquitofish (i.e. individuals >2 cm [24]) were collected
using dip nets from a wild population (37 540 2800 S, 145 080 1600 E) and
transported to Monash University for housing and experimentation. Given
femalemosquitofish take18–70days to fullymature[24] andhavea life span
of approximately 18 months [25], the expected age range for those used in
this study is 2–18 months. During housing, fish were maintained in glass
aquaria (60  30  30 cm; length  width  height; 30 fish per tank)
containing carbon-filtered fresh water at 23–25 C (12:12 h light:dark cycle),
with this water being left to stand for 24 h before being added to tanks. Fish
were fed ad libitum once daily with commercial fish food (Otohime Hirame
larval diet). After one month of acclimation to laboratory conditions, fish
were randomly allocated to one of three treatments for 28 days: unexposed
(i.e. 0 ng/L), low fluoxetine (nominal level: 30 ng/L) or high fluoxetine
(nominal level: 300 ng/L). The low- and high-fluoxetine concentrations were
selected based on the typical reported concentrations in freshwater
ecosystems (i.e. <0.1–351 ng/L [5]) and dosages employed in previously
published studies [18,26,27]. The exposure system followed previously
established protocols [28–30]. Specifically, fish were allocated to one of six
separate flow-through systems, with each system comprising of four
exposure aquaria, resulting in eight replicate tanks per treatment (60 
30  30 cm; water depth: 25 cm).
All systems received a constant supply of aged, carbon-filtered fresh
water (pH measured range: 6.9–7.9), with complete volume renewal
every 24 h. The exposed flow-through systems each received a constant
supply of fluoxetine (CAS: 56296-78-7) stock solution in reverse osmosis
water (low = 6 mg/L and high =60 mg/L), which was changed daily.
Fluoxetine stock solutions were prepared as described in Martin et al. [22]
and Bertram et al. [28]. Briefly, on every day of the exposure, a 1 mL
solution of fluoxetine hydrochloride and methanol (Sigma-Aldrich;
Product Number: F132; low: 18 ug/mL, high: 180 ug/mL) was evaporated
to dryness under a gentle nitrogen stream, before being diluted with Milli-
Q water to form a 3 L stock solution.
During the exposure, water temperature was maintained at 23.4  0.9
C (mean  SD; n = 576) and lighting and feeding conditions were
identical to those employed during laboratory housing (see above).
Further, weekly water samples (80 mL) were drawn from all exposure
tanks to measure fluoxetine concentrations, and fortnightly samples
drawn from all unexposed tanks to confirm the absence of contamination.
Analytical verification of fluoxetine concentrations was performed using
gas chromatography coupled to tandem mass spectrometry, as described
in Bertram et al. [28].
Behavioural experiments
A light/dark transition test was used as a proxy for measuring anxiety-
like behaviour. The experimental assay used in our study followed similar
procedures to those of several published studies addressing the impacts of
various toxicants on the locomotor response of juvenile fish [31–34] but
were modified for adult fish. Specifically, fish were placed individually
into square experimental arenas (18.5  18.5 cm; water depth: 5 cm) in
fresh water. Experimental arenas were then transferred into a cuboid
enclosure (maintained at 24 C) designed for automated behavioural
tracking (ZebraCube; ViewPoint Life Sciences). In total, 112 fish were
used in light/dark transition experiments (n: unexposed = 38, low-
fluoxetine = 38, high-fluoxetine = 36).
Before the start of each trial, fish were acclimated for 5 min within the
experimental arenas in complete darkness. After acclimation, the swimming
activity of the fish was measured continuously over a 20-min trial. To
measure the response of fish to shifts in light condition, two different light
conditions were employed while fish were inside the enclosure, complete
darkness or bright light (170–200 lx). This was achieved by turning lights on
and off in 5 min intervals, giving four distinct photoperiods (i.e. dark, light,
dark, light). Lights and live video tracking were controlled remotely
(ZebraLab tracking software v3.22; ViewPoint Life Sciences), with a
combination of LED and infrared lighting used to contrast the fish for
automated tracking. The swimming activity of fish was measured as the
number of pixels moved and was converted to physical distance (cm) using a
standard reference (i.e. the length of the arena, 18.5 cm). The following
endpoints were recorded for each fish: (1) light/dark response, measured as
the difference in activity levels between the light conditions (swimming
activity in the light minus swimming activity in the dark), and (2) general
swimming activity during each of the four photoperiods.
After completing the trials, fish were euthanised and morphological
measurements were taken. Specifically, following previously established
protocols [27,35,36], weight (0.0001 g) and standard length (0.01
mm; the tip of the snout to the end of the last vertebra) were measured for
each fish. Weight and length data for fish used in the present study has
been reported as part of Martin et al. [29], thus the main effects of
fluoxetine on weight or length will not be tested here (see Figure S1 for
data). It is worth highlighting that there was no significant difference in
the weight or length of fish across the exposure treatments [29].
Statistics
Data analyses were performed using R version 4.0.0 [37]. To
approximate a Gaussian distribution, data were transformed where
necessary (see Table S1 for descriptions). Both the light/dark response
and general swimming activity were analysed using a linear mixed-effects
(LME) model. The light/dark response model included fish weight (g),
transition number (the first or second light transition), exposure
treatment (unexposed, low fluoxetine or high fluoxetine), and exposure
treatment interaction terms as fixed effects, with fish identity included as
a random intercept. The model for swimming activity included fish
weight, light treatment (i.e. dark or light), transition number, exposure
treatment, and exposure treatment interaction terms as fixed effects. In
addition, fish identity was included as a random intercept, with transition
number and light treatment modelled as random slopes, to account for
variability in individual differences in behaviour across transition
number and light treatments. Across all models, fish weight was centred
to improve the interpretability of main effects. Where interaction terms
were non-significant (i.e. p > 0.05) and did not improve the fit of the
model—assessed using Akaike information criterion (AIC) estimates—
they were removed (see Table S1 for final models). For all models, type-II
Wald’s F-tests with Kenward-Roger Degrees of Freedom Approximation
were used to calculate the p-values of fixed effects and interaction terms.
Where a significant main effect of exposure treatment was detected,
Tukey’s p-adjustments were used to investigate pair-wise comparisons.
Further, where a significant interaction term was detected between a
categorical and continuous predictor, the relationship was investigated
with Pearson’s correlation tests within each category.
Results
Analytical verification of fluoxetine concentrations
During the 28-day exposure period, the average measured concen-
trations ( SD) of the low- and high-fluoxetine treatments were 18.19 
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4.98 ng/L (n = 32) and 214.69  38.89 ng/L (n = 32), respectively.
Fluoxetine was not detected (i.e. was under the detection limit; less than 2
ng/L, n = 16) in control water samples.
Fish behaviour
There were no significant interactions between any predictors for
light/dark response (all p > 0.05; see Table S1). We did observe a
significant effect of fluoxetine exposure treatment (F2,108 = 3.10, p =
0.049; Fig. 1). Specifically, there was a difference between the light/dark
response of unexposed and low-exposed fish, with a comparatively
smaller change in swimming activity observed in low-exposed females
between the dark and light condition (z = 2.48, p = 0.035). However, we
saw no significant difference in the light/dark response of fish across the
other treatment comparisons (z = 1.43, p = 0.326 and z = 1.03, p =
0.558, unexposed–high and low–high, respectively). In addition, there
was a significant main effect of transition number (F1,111 = 13.40, p <
0.001). Specifically, on average, fish adjusted their swimming activity
more substantially in the first light transition (Dactivity mean  SE:
134.83  3.47) compared to the second transition (48.46  3.47).
There was no significant main effect of fish weight on light/dark response
(F1,108= 0.12, p = 0.732). Fish identity accounted for an estimated 15.90
 0.09 % (mean  SE) of the variation in light/dark response.
For swimming activity, we detected a significant interaction between
exposure treatment and fish weight (F2,106= 3.56, p = 0.032; Fig. 2). For
unexposed fish and high-fluoxetine exposed fish, there was a non-
significant positive correlation between fish weight and swimming
activity (r = 0.27, p = 0.102 and r = 0.27, p = 0.111), whereas for low-
fluoxetine exposed fish there was a non-significant negative correlation (r
= 0.24, p = 0.156). In addition, there were significant main effects of
both light treatment (F1,111 = 40.66, p < 0.001) and transition number
(F1,111 = 296.70, p < 0.001). Individual fish identity accounted for an
estimated 39.2  3.70 (mean  SE) of the variation in swimming activity.
Discussion
Fluoxetine exposure resulted in a nonmonotonic decrease in light/
dark response. Specifically, a significant difference in the light/dark
response of low-exposed fish and unexposed fish was observed, while
there was no significant difference between the other treatments.
Compared to fish from the unexposed treatment, low-exposed fish were
less responsive to shifts in environmental light condition, maintaining
similar activity levels across both light and dark periods.
This reduction in locomotor-based response to the light condition is
interpreted as a shift in anxiety-related behaviour for several reasons.
First, a preference for dark environments over bright environments has
been validated in a number of teleost species [38–40], and the strength of
this preference is commonly used as an indicator of anxiety [41],
including in mosquitofish [18,42]. Second, anxiety-like responses to
light/dark transition tests have been experimentally confirmed in fish
(e.g. juvenile zebrafish [34]). Third, within this study, a reduction in
activity levels during the light photoperiods was observed, which is a
common response in fish (e.g. [43–45]), including mosquitofish [22], to
perceived threatening situations. Lastly, given that fluoxetine acts on
evolutionarily conserved neuroendocrine pathways involved in the stress
response [15], changes to anxiety-like behaviour are an expected impact
on adult fish from an adverse outcome pathway (AOP) perspective [15].
We should highlight that it is possible that fluoxetine-induced changes in
general locomotor performance (via muscular/skeletal dysfunctions)
may also explain shifts in the light/dark response. However, despite
evidence that SSRI exposure can alter bone development in exposed
embryos [46], to the best of our knowledge, these effects have not been
reported during adult exposure, or at environmentally realistic concen-
trations. Further, a general impairment of locomotion is unlikely in this
study, as we did not detect a general change in locomotor activity across
the treatments, only in the relative response to the dark and light
photoperiods. Therefore, the most plausible explanation for fluoxetine-
induced changes in the light/dark response is disrupted anxiety-related
behaviour.
On an individual level, anxiety-like behaviour has been linked to a
number of ecologically important processes, such as risk of predation,
foraging efficiency, and dispersal tendency [47–50]. Wild fish must
constantly adjust their behaviour based on perceived level of risk, as many
fitness-related behaviours (e.g. foraging, reproduction) are typically
associated with increased threat of predation [51]. Therefore, pollutant-
induced reductions in anxiety-like behaviour—as seen here—could
potentially increase predation risk as a result of suboptimal behaviour in
potentially dangerous situations. With that said, it is important to note
that the optimal behaviour of any individual depends on a range of social
and environmental factors, such as predator presence, population size,
and food density [17,51]. As such, the realised impacts of fluoxetine-
induced behavioural changes are difficult to predict and warrant further
investigation. Despite uncertainty surrounding the magnitude of
ecological consequences, it is reasonable to assume that a pollutant-
induced perturbation of anxiety-related behaviours could have important
fitness consequences for exposed wildlife at the population level [48].
The results of the present study are concordant with five earlier studies
[19,22,52–54] that have all reported a decrease in anxiety-related
behaviours of fish as a result of environmentally realistic SSRI exposure
(see Table S2 for study details). However, our findings contrast with three
studies [21,55,56] reporting an increase in anxiety-related behaviour, as
well as four [20,36,44,57] that report no effect of SSRI exposure on
anxiety-related behaviour (Table S2). It is important to point out that
differences in the literature between reported effects of fluoxetine are not
limited to anxiety-related behaviour. Indeed, variability between
reported effects of fluoxetine on aquatic wildlife has been the subject
of debate more generally [58,59].
We contend that the apparent variability across studies is likely the
result of one or more of the following factors: differences in study species,
Fig. 1. Light/dark response, measured as the difference in activity levels between
the light and dark photoperiods (i.e. light activity minus dark activity; cm), for fish
in the unexposed (n = 38), low-fluoxetine (n = 38) and high-fluoxetine (n = 36)
treatments. Data from the first light transition and the second light transition are
represented by open circles and triangles, respectively. Values below zero indicate
increased activity in the dark photoperiod (i.e. area shaded grey), while values
above zero indicate increased activity in the light photoperiod (i.e. area shaded
white). Box plots show 25th, 50th (median), and 75th percentiles. Groups that
share a capital letter are not significantly different from one another.
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exposure durations, and exposure concentrations. In this regard, there is
evidence to suggest that effects of fluoxetine can be mediated by all of the
above factors. For example, species-specific sensitivity may contribute to
this variability, as many of the neuroendocrine pathways through which
fluoxetine alters behaviour vary substantially across species [60].
Further, it is well established that the impacts of fluoxetine are time-
dependent, where acute and chronic effects can have different, even
conflicting, impacts on behaviour [58]. In addition, previous studies, as
well as the present, have reported fluoxetine-induced nonmonotonic
dose–response relationships [18,19,22,23,55,61–65]. There is also
evidence to suggest that the bioaccumulation of fluoxetine in fish tissue
is pH-dependent (e.g. Japanese medaka, Oryzias latipes [66]), and among-
study variability in bioaccumulation and bioconcentration factors have
been linked to differences in water pH (see [18]). With this in mind, it is
perhaps unsurprising that studies using different concentrations,
exposure durations, species, and water parameters have reported
different effects on behaviour. Provided that one or more of the above
dose–response relationships (i.e. species-specificity, temporal variation,
or nonmonotonicity) are possible at environmentally realistic levels, we
must be careful not to disregard low-dose effects as artefacts due to a
perceived lack of cross-study repeatability.
As mentioned above, the present findings are suggestive of a
nonmonotonic dose–response relationship, as the magnitude of the
reported effect did not increase linearly with dosage. Evidence for
nonmonotonic effects is increasingly reported at environmentally
realistic dosages of fluoxetine across a wide range of species, including
studies investigating anxiety-like behaviour and antipredator behaviour
in fish [18,19,22,55,63,67]. Consistent with the result observed in the
present study, Martin et al. [18] reported a significant reduction in
anxiety-related behaviour in mosquitofish at the lower of two
environmentally realistic fluoxetine dosage (61 ng/L for 28 days) using
a scototaxis assay, but did not detect a difference at the higher dosage
(352 ng/L). Similarly, Painter et al. [19] reported evidence for a
nonmonotonic effect of fluoxetine exposure on fish behaviour (fathead
minnow, Pimephales promelas; 25–250 ng/L for 5 days as embryos), with
more pronounced reductions in antipredator behaviour detected at lower
dosages. More broadly, nonmonotonic dose–response relationships could
result from a number of different mechanisms, such as receptor
desensitisation, negative feedback with increasing dose, dose–dependent
metabolism modulation, or opposing effects induced by an analyte
binding to multiple receptors that differ in their affinity [68]. It is possible
that such mechanisms are driving the reported nonmonotonic effects of
fluoxetine in aquatic wildlife. With increasing evidence for fluoxetine-
induced nonmonotonic effects, the potential mechanisms driving this
relationship clearly warrant further investigation.
Interestingly, we detected an interaction between fish size (i.e.
weight) and fluoxetine exposure treatment on swimming activity. This
interaction appeared to be driven by a positive relationship between fish
size and swimming activity in the unexposed and high-fluoxetine
treatments, compared to a negative relationship in the low-fluoxetine
treatment. On further investigation, the relationship between fish size
and swimming activity was not statistically significant within each
treatment (i.e. unexposed, low-fluoxetine or high-fluoxetine). Therefore,
despite detecting a statistically significant interaction, we suggest that
fluoxetine-induced changes in the relationship between fish size and
anxiety-like behaviour be verified with additional studies. Still, this is not
the first time such an interaction has been shown, with Martin et al. [18]
reporting that fluoxetine disrupted the relationship between fish size and
anxiety-like behaviour in mosquitofish. We contend that a mass-specific
uptake of fluoxetine could be a mechanism driving fluoxetine-induced
changes in the relationship between behaviour and body size. Indeed, a
negative relationship between the tissue concentration of fluoxetine and
fish body size has previously been documented [18]. Although the
generality of mass-specific effects of fluoxetine remains to be tested, it is
important to highlight this result, as the presence of a mass-dose
relationship for fluoxetine exposure may provide insights when
comparing reported effects across previous studies.
Conclusions
Here we report that antidepressant exposure at field-detected levels
can disrupt the behaviour of non-target species, like fish. Further, these
effects appeared to be nonmonotonic, with stronger effects reported at the
lower of two fluoxetine dosages. Importantly, contaminant-induced
changes in anxiety-related behaviour, as reported here, could alter
predator-prey interactions with consequences for population fitness.
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